Veterinary Medicine Information website

Dexafort Suspension for Injection

Authorised
  • DEXAMETHASONE 21-PHENYLPROPIONATE
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
Dexafort Suspension for Injection
Active substance:
  • DEXAMETHASONE 21-PHENYLPROPIONATE
  • Dexamethasone sodium phosphate
Target species:
  • Cattle
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • DEXAMETHASONE 21-PHENYLPROPIONATE
    2.67
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone sodium phosphate
    1.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        53
        day
      • Milk
        6
        day
    • Horse
      • Meat and offal
        47
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Clear glass (Type I Ph. Eur.) vials of 50 ml closed with a halogenated butylrubber stopper and sealed with an aluminium cap with or without a blue plastic flip-off cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vet Pharma Friesoythe GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/028/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 27/07/2025
Download